Navigation path

Pharmaceuticals - Community Register

  

Community list of not active orphan medicinal products


WITHDRAWN  

Product information

Recombinant human alpha-1 antitrypsin

EU orphan designation number: EU/3/02/100
Active ingredient: Recombinant human alpha-1 antitrypsin
Indication: Treatment of emphysema secondary to congenital alpha-1-antitrypsin deficiency
Sponsor: Aptiv Solutions (UK) Ltd
3 Glory Park Avenue, Wooburn Green, Bucks HP10 0DF, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
03/05/2002 Centralised Orphan - Designation EMEA/OD/048/01 (2002)1829 of 30/04/2002
19/10/2006 Centralised Orphan - Transfer of orphan designation EMEA/OD/048/01/T/01 (2006)5012 of 17/10/2006
29/07/2008 Centralised Orphan - Transfer of orphan designation EMEA/OD/048/01/T/02 (2008)4098 of 25/07/2008
09/11/2010 Other procedure EMA/581201/2010
14/03/2011 Other procedure EMEA/OD/048/01
21/05/2012 Other procedure